Literature DB >> 33384436

Deposition distribution of the new coronavirus (SARS-CoV-2) in the human airways upon exposure to cough-generated droplets and aerosol particles.

Balázs G Madas1, Péter Füri2, Árpád Farkas2, Attila Nagy3, Aladár Czitrovszky3,4, Imre Balásházy2, Gusztáv G Schay5, Alpár Horváth6,7.   

Abstract

The new coronavirus disease 2019 (COVID-19) has been emerged as a rapidly spreading pandemic. The disease is thought to spread mainly from person-to-person through respiratory droplets produced when an infected person coughs, sneezes, or talks. The pathogen of COVID-19 is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It infects the cells binding to the angiotensin-converting enzyme 2 receptor (ACE2) which is expressed by cells throughout the airways as targets for cellular entry. Although the majority of persons infected with SARS-CoV-2 experience symptoms of mild upper respiratory tract infection, in some people infections of the acinar airways result in severe, potentially fatal pneumonia. However, the induction of COVID-19 pneumonia requires that SARS-CoV-2 reaches the acinar airways. While huge efforts have been made to understand the spread of the disease as well as the pathogenesis following cellular entry, much less attention is paid to how SARS-CoV-2 from the environment reach the receptors of the target cells. The aim of the present study is to characterize the deposition distribution of SARS-CoV-2 in the airways upon exposure to cough-generated droplets and aerosol particles. For this purpose, the Stochastic Lung Deposition Model has been applied. Particle size distribution, breathing parameters supposing normal breathing through the nose, and viral loads were taken from the literature. We found that the probability of direct infection of the acinar airways due to inhalation of particles emitted by a bystander cough is very low. As the number of viruses deposited in the extrathoracic airways is about 7 times higher than in the acinar airways, we concluded that in most cases COVID-19 pneumonia must be preceded by SARS-CoV-2 infection of the upper airways. Our results suggest that without the enhancement of viral load in the upper airways, COVID-19 would be much less dangerous. The period between the onset of initial symptoms and the potential clinical deterioration could provide an opportunity for prevention of pneumonia by blocking or significantly reducing the transport of viruses towards the acinar airways. Therefore, even non-specific treatment forms like disinfection of the throat and nasal and oral mucosa may effectively keep the viral load of the upper airways low enough to avoid or prolong the progression of the disease. In addition, using a tissue or cloth in order to absorb droplets and aerosol particles emitted by own coughs of infected patients before re-inhalation is highly recommended even if they are alone in quarantine.

Entities:  

Year:  2020        PMID: 33384436     DOI: 10.1038/s41598-020-79985-6

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  2 in total

1.  The de Winter Electrocardiogram Pattern Evolving From Hyperacute T Waves.

Authors:  Yi-Wei Cao; Hao-Yu Wu; Lei Liang
Journal:  JAMA Intern Med       Date:  2021-03-01       Impact factor: 21.873

2.  SARS-CoV-2 asymptomatic and symptomatic patients and risk for transfusion transmission.

Authors:  Victor M Corman; Holger F Rabenau; Ortwin Adams; Doris Oberle; Markus B Funk; Brigitte Keller-Stanislawski; Jörg Timm; Christian Drosten; Sandra Ciesek
Journal:  Transfusion       Date:  2020-05-27       Impact factor: 3.337

  2 in total
  17 in total

1.  Duality Between Coronavirus Transmission and Air-Based Macroscopic Molecular Communication.

Authors:  Max Schurwanz; Peter Adam Hoeher; Sunasheer Bhattacharjee; Martin Damrath; Lukas Stratmann; Falko Dressler
Journal:  IEEE Trans Mol Biol Multiscale Commun       Date:  2021-04-08

2.  A computed tomography imaging-based subject-specific whole-lung deposition model.

Authors:  Xuan Zhang; Frank Li; Prathish K Rajaraman; Jiwoong Choi; Alejandro P Comellas; Eric A Hoffman; Benjamin M Smith; Ching-Long Lin
Journal:  Eur J Pharm Sci       Date:  2022-07-29       Impact factor: 5.112

3.  Anatomy matters: The role of the subject-specific respiratory tract on aerosol deposition - A CFD study.

Authors:  Jana Wedel; Paul Steinmann; Mitja Štrakl; Matjaž Hriberšek; Yan Cui; Jure Ravnik
Journal:  Comput Methods Appl Mech Eng       Date:  2022-07-28       Impact factor: 6.588

Review 4.  Aerosol Transport Modeling: The Key Link Between Lung Infections of Individuals and Populations.

Authors:  Chantal Darquenne; Azadeh A T Borojeni; Mitchel J Colebank; M Gregory Forest; Balázs G Madas; Merryn Tawhai; Yi Jiang
Journal:  Front Physiol       Date:  2022-06-20       Impact factor: 4.755

Review 5.  Review of non-invasive detection of SARS-CoV-2 and other respiratory pathogens in exhaled breath condensate.

Authors:  Emeka Nwanochie; Jacqueline C Linnes
Journal:  J Breath Res       Date:  2022-03-18       Impact factor: 4.538

6.  Study on Factors of People's Wearing Masks Based on Two Online Surveys: Cross-Sectional Evidence from China.

Authors:  Ling Zhang; Sirong Zhu; Hui Yao; Mengying Li; Guanglin Si; Xiaodong Tan
Journal:  Int J Environ Res Public Health       Date:  2021-03-26       Impact factor: 3.390

7.  Excellent option for mass testing during the SARS-CoV-2 pandemic: painless self-collection and direct RT-qPCR.

Authors:  Eva Kriegova; Regina Fillerova; Milan Raska; Jirina Manakova; Martin Dihel; Ondrej Janca; Pavel Sauer; Martina Klimkova; Petra Strakova; Petr Kvapil
Journal:  Virol J       Date:  2021-05-04       Impact factor: 4.099

8.  Modeling of nursing care-associated airborne transmission of SARS-CoV-2 in a real-world hospital setting.

Authors:  Attila Nagy; Alpár Horváth; Árpád Farkas; Péter Füri; Tamás Erdélyi; Balázs G Madas; Aladár Czitrovszky; Béla Merkely; Attila Szabó; Zoltán Ungvári; Veronika Müller
Journal:  Geroscience       Date:  2022-01-05       Impact factor: 7.581

9.  Risk Assessment of Infection by Airborne Droplets and Aerosols at Different Levels of Cardiovascular Activity.

Authors:  Jana Wedel; Paul Steinmann; Mitja Štrakl; Matjaž Hriberšek; Jure Ravnik
Journal:  Arch Comput Methods Eng       Date:  2021-07-01       Impact factor: 7.302

10.  SARS CoV-2 aerosol: How far it can travel to the lower airways?

Authors:  Mohammad S Islam; Puchanee Larpruenrudee; Akshoy Ranjan Paul; Gunther Paul; Tevfik Gemci; Yuantong Gu; Suvash C Saha
Journal:  Phys Fluids (1994)       Date:  2021-06-03       Impact factor: 3.521

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.